Trial First to Show Improvements in Alzheimer's Patients
Trial First to Show Improvements in Alzheimer's Patients News provided by Share this article Share this article BURLINGAME, Calif., May 13, 2021 /PRNewswire/ -- Pharmaceutical trials for Alzheimer's have failed repeatedly, but a new study, using a fundamentally different approach, has provided the first success: using precision medicine to identify and target the drivers of Alzheimer's or pre-Alzheimer's in each patient, a team of physicians and researchers has posted exciting, positive results in medRxiv, the Yale-backed site for health sciences. (PRNewsfoto/Apollo Health) (PRNewsfoto/Apollo...